The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers

[1] Zhang Y-y(2020)Ning B-t. The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections Front Immunol 11 2033-e22

[2] Li B-r(2021)COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1–April 30, 2021 Morb Mortal Wkly Rep 70 792-69

[3] Covid C(2022)The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries The Lancet Public Health 7 e15-16

[4] Team VBCI(2021)COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre-and post-marketing evidence for vaccine efficacy and safety Drug Saf 44 1247-e806

[5] Birhane M(2021)COVID-19 prevalence among Healthcare Workers. A systematic review and Meta-analysis Int J Environ Res Public Health 19 146-84

[6] Bressler S(2021)Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study The Lancet 398 1407-R5

[7] Chang G(2022)Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy EBioMedicine 80 104042-8

[8] Clark T(2022)Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study The Lancet Global Health 10 e798-902

[9] Mills MC(2022)Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine JAMA Intern Med 182 179-65

[10] Rüttenauer T(2017)Animal communication: when i’m calling you, will you answer too? Curr Biol 27 R713-20

[1] Zhang Y-y(2020)Ning B-t. The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections Front Immunol 11 2033-e22

[2] Li B-r(2021)COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1–April 30, 2021 Morb Mortal Wkly Rep 70 792-69

[3] Covid C(2022)The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries The Lancet Public Health 7 e15-16

[4] Team VBCI(2021)COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre-and post-marketing evidence for vaccine efficacy and safety Drug Saf 44 1247-e806

[5] Birhane M(2021)COVID-19 prevalence among Healthcare Workers. A systematic review and Meta-analysis Int J Environ Res Public Health 19 146-84

[6] Bressler S(2021)Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study The Lancet 398 1407-R5

[7] Chang G(2022)Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy EBioMedicine 80 104042-8

[8] Clark T(2022)Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study The Lancet Global Health 10 e798-902

[9] Mills MC(2022)Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine JAMA Intern Med 182 179-65

[10] Rüttenauer T(2017)Animal communication: when i’m calling you, will you answer too? Curr Biol 27 R713-20